Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Molecular pathways altered by insulin b9-23 immunization.

Sarah E Eckenrode1, Qing-Guo Ruan, Christin D Collins

  • 1CBGM, Medical College of Georgia, 1120 15th Street, CA-4124, Augusta, GA 30912, USA.

Annals of the New York Academy of Sciences
|February 9, 2005
PubMed
Summary

Insulin peptide therapy delays type 1 diabetes in nonobese diabetic mice by reducing pro-inflammatory lymphocyte activation. This treatment upregulates Th2-promoting genes, offering a molecular explanation for its protective effects.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pathogen-specific immune responses might underlie divergent outcomes of coronavirus and influenza infection in the natural porcine host.

Communications biology·2026
Same author

Family history of type 2 diabetes delays development of type 1 diabetes in TEDDY children with islet autoimmunity.

Diabetologia·2025
Same author

Short-chain per- and polyfluoroalkyl substances associate with elevated alanine aminotransferase: Cross-sectional analysis results from the STRIVE cohort.

Environmental research·2025
Same author

Porcine respiratory coronavirus as a model for acute respiratory disease: mechanisms of different infection outcomes.

Journal of immunology (Baltimore, Md. : 1950)·2025
Same author

Predictors of hepatocellular carcinoma in LR-M category lesions, a multi-institutional analysis.

Abdominal radiology (New York)·2025
Same author

Off-On Photo- and Redox-Triggered Anion Transport Using an Indole-Based Hydrogen Bond Switch.

ACS omega·2024

Area of Science:

  • Immunology
  • Endocrinology
  • Genetics

Background:

  • Type 1 diabetes (T1D) development in nonobese diabetic (NOD) mice can be postponed using insulin or specific insulin peptides.
  • Understanding the molecular mechanisms behind insulin's protective effects is crucial for T1D therapeutic development.

Purpose of the Study:

  • To investigate the gene expression changes in the spleen of NOD mice following treatment with an insulin peptide (B9-23).
  • To elucidate the molecular basis of how B9-23 therapy delays autoimmune diabetes onset in NOD mice.

Main Methods:

  • Comparison of gene expression profiles in spleen tissue from B9-23 treated NOD mice, age-matched NOD mice, and NOD congenic mice using cDNA microarray.
  • Analysis of gene expression alterations during natural disease progression in NOD mice.

Related Experiment Videos

Main Results:

  • Fifty genes showed significant alterations upon B9-23 treatment.
  • Thirty-three downregulated genes in treated mice mirrored genes upregulated during natural T1D progression in NOD mice, suggesting reduced pro-inflammatory lymphocyte activation.
  • Increased expression of Irf4 and Tra1 genes, known to promote Th2 responses, was observed in B9-23 treated mice.

Conclusions:

  • B9-23 insulin peptide therapy appears to delay T1D by suppressing pro-inflammatory lymphocyte activation, similar to protective genes found in NOD congenic strains.
  • The upregulation of Irf4 and Tra1 provides a molecular mechanism for the observed protective effects of B9-23 therapy, potentially by shifting the immune response towards a Th2 profile.